Title

Gene Therapy In The Post-Gelsinger Era

Abstract

As gene therapy research races to a first cure of a genetic-based disease, the research community has struggled with the aftermath of the well-publicized death of Jesse Gelsinger from complications of an experimental treatment. In a wrongful death lawsuit against the University of Pennsylvania and its researchers, Jesse Gelsinger’s family alleged violations of federal regulations and research ethics. This article reviews gene therapy research, examines the role of the key players in this tragedy, and provides suggestions for preventing future misfortunes. © 2002 Lippincott Williams & Wilkins, Inc.

Publication Date

1-1-2002

Publication Title

JONA's Healthcare Law, Ethics, and Regulation

Volume

4

Issue

4

Number of Pages

104-110

Document Type

Article

Personal Identifier

scopus

DOI Link

https://doi.org/10.1097/00128488-200212000-00004

Socpus ID

0036885931 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/0036885931

This document is currently not available here.

Share

COinS